Form 4: BDX Director Carrie Byington Receives RSU Grant

Becton Dickinson & Co. Director Carrie L. Byington was granted 1,098 restricted stock units under a pre-arranged 10b5-1 plan.

Summary

• Carrie L. Byington, a Director of Becton Dickinson & Co. (BDX), acquired 1,098 shares of common stock.
• The acquisition occurred on January 27, 2026, and represents a grant of restricted stock units (RSUs) under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
• The transaction price was $0 per share, indicating an award rather than a purchase.
• Following this transaction, Ms. Byington beneficially owns 5,018 shares, which includes units acquired through dividend investment since her last report.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard corporate governance practices where director compensation includes equity, aligning their interests with long-term company performance.

Positives

• A Director received an equity grant, which aligns management's long-term interests with those of shareholders.
• The transaction was conducted under a Rule 10b5-1 plan, enhancing transparency and demonstrating a pre-planned approach to insider trading.

Future Outlook

This filing reports a specific insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in the healthcare industry, aligning their long-term interests with the company's performance and shareholder value. The use of a 10b5-1 plan for such grants is also a common governance practice to ensure compliance and transparency.

Comparison to Industry Standards

• Equity compensation for directors, particularly through restricted stock units, is a widely adopted practice across large-cap healthcare companies, including peers like Medtronic (MDT) and Johnson & Johnson (JNJ).
• The grant of 1,098 units, valued at the time of grant, is consistent with typical director compensation structures that blend cash retainers with equity awards to incentivize long-term commitment and performance.

Corporate Governance

Related Party Transactions

• Grant of 1,098 restricted stock units to Director Carrie L. Byington as part of her compensation under the company's 2004 Employee and Director Equity-Based Compensation Plan.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: The transaction utilizes a company-wide equity compensation plan, which also covers employees, reinforcing a broader compensation strategy.

Key Dates

Recommendation

The filing reports a routine equity grant to a director, which is a standard compensation practice and aligns management's interests with shareholders. This type of transaction does not typically indicate a significant change in the company's fundamental outlook, thus a 'hold' recommendation is appropriate as it provides no new material information to alter an existing investment thesis.

Keywords

Becton Dickinson, BDX, Carrie Byington, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Equity Compensation, 10b5-1 Plan